Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 |
| Revenues | 6.0 | 5.5 | -9.4 | 1.6 | 0.1 |
| Revenue growth | 10.2% | -158.4% | -694.5% | 2440.3% | |
| Cost of goods sold | 14.8 | 10.5 | 6.4 | 2.0 | 0.1 |
| Gross profit | -8.8 | -5.0 | -15.8 | -0.4 | 0.0 |
| Gross margin | -145.4% | -91.9% | 168.4% | -26.1% | 14.5% |
| Sales and marketing | 10.3 | 23.7 | 5.4 | 6.5 | 5.5 |
| Research and development | 95.1 | 93.3 | 57.0 | 59.4 | 48.3 |
| General and administrative | 19.2 | 35.6 | 3.8 | 3.2 | 2.4 |
| EBIT | -133.3 | -157.7 | -82.0 | -69.5 | -56.3 |
| EBIT margin | -2212.9% | -2884.2% | 875.5% | -4410.0% | -90743.5% |
| Pre-tax income | -126.5 | -153.3 | -81.3 | -67.3 | -56.4 |
| Income taxes | -0.3 | -0.3 | -0.2 | 0.0 | 0.0 |
| Tax rate | 0.3% | 0.2% | 0.2% | 0.0% | |
| Net income | -126.5 | -153.3 | -81.3 | -67.3 | -56.4 |
| Net margin | -2100.0% | -2804.2% | 868.5% | -4272.4% | -90967.7% |
| |
| Diluted EPS | ($0.94) | ($1.49) | ($4.92) | ($4.33) | ($3.75) |
| Shares outstanding (diluted) | 135.2 | 102.9 | 16.5 | 15.5 | 15.0 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|